1. 1-24 of 3423 1 2 3 4 ... 141 142 143 »
    1. Kala Pharmaceuticals Announces Appointment of C. Daniel Myers to Board of Directors

      Kala Pharmaceuticals Announces Appointment of C. Daniel Myers to Board of Directors

      WATERTOWN, Mass., Oct. 18, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced the appointment of C. Daniel Myers to its Board of Directors...

      Read Full Article
    2. Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid

      Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid

      CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, today announced that the Delaware Court of Chancery found that CytoDyn’s Board of Directors properly rejected a nomination notice presented by an activist group led by Paul Rosenbaum and Bruce Patterson...

      Read Full Article
    1-24 of 3423 1 2 3 4 ... 141 142 143 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content